CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) crossed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $52.01 and traded as high as $54.00. CochLear shares last traded at $53.09, with a volume of 13,588 shares traded.
Analysts Set New Price Targets
A number of research firms have weighed in on CHEOY. Royal Bank Of Canada cut shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price objective on the stock. in a report on Thursday, July 16th. Jefferies Financial Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. Finally, Canaccord Genuity Group downgraded shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 18th. Five analysts have rated the stock with a Hold rating. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $117.00.
View Our Latest Stock Analysis on CHEOY
CochLear Trading Up 1.1%
The company has a fifty day moving average of $48.30 and a two-hundred day moving average of $51.83.
About CochLear
Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions for people with moderate to profound hearing loss. Its portfolio includes cochlear implants, bone conduction implants and related sound processors, accessories and connectivity products designed to help users hear in a range of environments.
The company also provides clinical support, rehabilitation resources, software, technical services and ongoing care for recipients, clinicians and hearing professionals.
Recommended Stories
- Five stocks we like better than CochLear
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
